Accelerated radiotherapy for advanced laryngeal cancer

References

• Haugen H, Johansson K-A, Mercke C. Hyperfractionated-accelerated or conventionally fractionated radiotherapy for early glottic cancer. Int J Radiat Oncol Biol Phys 2002; 52: 109–19
   PubMedGoogle Scholar
• Garden AS, Forster K, Wong P-F, Morrison WH, Schechter NR, Ang KK. Results of radiotherapy for T2N0 glottic carcinoma: does the “2” stand for twice- daily treatment?. Int J Radiat Oncol Biol Phys 2003; 55: 322–8
   PubMed Web of Science ®Google Scholar
• Finizia C, Geterud Å, Holmberg E, Lindström J, Lundgren J, Klintberg C, et al. Advanced laryngeal cancer T3-T4 in Sweden: retrospective study 1986–1990. Survival and locoregional control related to treatment. Acta Otolaryngol 1996; 116: 906–12
   PubMed Web of Science ®Google Scholar
• Union Internationale Contre le Cancer. TNM Classification of Malignant Tumors. Fourth Fully Revised Edition. Berlin, Heidelberg, New York, London, Paris, Tokyo: Springer-Verlag; 1987. p. 24–26.
   Google Scholar
• Mehta M, Scrimger R, Mackie R, Paliwal B, Chappell R, Fowler J. A new approach to dose escalation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2001; 49: 23–33
   PubMed Web of Science ®Google Scholar
• Trotti A, Byhardt R, Stetz J, Gwede C, Corn B, Fu K, et al. Common Toxicity Criteria: version 2.0. An improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. Int J Radiat Oncol Biol Phys 2000; 47: 13–47
   PubMed Web of Science ®Google Scholar
• Jörgensen K, Godballe C, Hansen O, Bastholt L. Cancer of the larynx. Treatment results after primary radiotherapy with salvage surgery in a series of 1005 patients. Acta Oncol 2002; 41: 69–76
   PubMed Web of Science ®Google Scholar
• Nguyen-Tan PF, Le Q-T, Quynh-Thu J-M, Quivey J-M, Singer M, Terris DJ, Goffinet DR, et al. Treatment results and prognostic factors of advanced T3-4 laryngeal carcinoma: the University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experience. Int J Radiat Oncol Biol Phys 2001; 50: 1172–80
   PubMedGoogle Scholar
• Harwood AR, Beale FA, Cummings BJ, Hawkins NV, Keane TJ, Rider WD. T3 glottic cancer: an analysis of dose time- volume factors. Int J Radiat Oncol Biol Phys 1980; 6: 675–80
   PubMed Web of Science ®Google Scholar
• Parsons JT, Mendenhall WM, Stringer SP, Cassisi NJ. T4 laryngeal carcinoma: radiotherapy alone with surgery reserved for salvage. Int J Radiat Oncol Biol Phys 1998; 40: 549–52
   PubMedGoogle Scholar
• Karim ABMF, Kralendonk JH, Njo KH, Tierie AH, Hasman A. Radiation therapy for advanced (T3T4N0-N3M0) laryngeal carcinoma: the need for a change of strategy: a radiotherapeutic viewpoint. Int J Radiat Oncol Biol Phys 1987; 13: 1625–33
   PubMed Web of Science ®Google Scholar
• Mendenhall WM, Parsons JT, Mancuso AA, Stringer SP, Cassisi NJ. Radiotherapy for squamous cell carcinoma of the supraglottic larynx: an alternative to surgery. Head and Neck 1996; 18: 24–35
   PubMedGoogle Scholar
• Wang CC, Nakfoor BM, Spiro IJ, Martin SP. Role of accelerated fractionated irradiation for supraglottic carcinoma: assessment of results. Cancer J Sci Am 1997; 3: 88–91
   PubMed Web of Science ®Google Scholar
• MacKenzie RG, Franssen E, Balogh JM, Gilbert RW, Birt D, Davidson J. Comparing treatment outcomes of radiotherapy and surgery in locally advanced carcinoma of the larynx: a comparison limited to patients eligible for surgery. Int J Radiat Oncol Biol Phys 2000; 47: 65–71
   PubMedGoogle Scholar
• Fu KF, Pajak TF, Trotti A, Jones U, Spencer SA, Philips TL, et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000; 48: 7–16
   PubMed Web of Science ®Google Scholar
• Zackrisson B, Mercke C, Strander H, Wennerberg J, Cavallin-Ståhl E. A systematic overview of radiation therapy effects in head and neck cancer. Acta Oncol 2003; 42: 443–61
   PubMed Web of Science ®Google Scholar
• Dische S, Saunders M, Barett A, Harvey A, Gibson D, Parmar M. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol 1997; 44: 123–36
   PubMed Web of Science ®Google Scholar
• Overgaard J, Sand Hansen H, Specht L, Overgaard M, Grau C, Andersen E, et al. Five compared to six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial. Lancet 2003; 362: 933–40
   PubMed Web of Science ®Google Scholar
• Pignon JP, Bourhis J, Domenge C, Designé L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. The Lancet 2000; 355: 949–55
   PubMed Web of Science ®Google Scholar
• Monnerat C, Faivre S, Temam S, Bourhis J, Raymond E. End points for new agents in induction chemotherapy for locally advanced head and neck cancers. Ann Oncol 2002; 13: 995–1006
   PubMed Web of Science ®Google Scholar
• Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003; 349: 2091–8
   PubMed Web of Science ®Google Scholar
• Castelijns JA, Becker M, Hermans R. Impact of cartilage invasion on treatment and prognosis of laryngeal cancer. Eur Radiol 1996; 6: 156–69
   PubMed Web of Science ®Google Scholar
• Pameijer FA, Mancuso AA, Mendenhall WM, Parsons JT, Kubilis PS. Can pretreatment computed tomography predict local control in T3 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy?. Int J Radiat Oncol Biol Phys 1997; 37: 1011–21
   PubMed Web of Science ®Google Scholar
• Castelijns JA, Golding RP, van Schaik C, Valk J, Snow GB. MR findings of cartilage invasion by laryngeal cancer: value in predicting outcome of radiation therapy. Radiology 1990; 174: 669–73
   PubMed Web of Science ®Google Scholar
• Million RR. The myth regarding bone or cartilage involvement by cancer and the likelihood of cure by radiotherapy. Head and Neck 1989; 11: 30–40
   PubMedGoogle Scholar
• Becker M, Zbären P, Läng H, Stoupis C, Porcellini B, Vock P. Neoplastic invasion of the laryngeal cartilage: comparison of MR imaging and CT with histopathologic correlation. Radiology 1995; 194: 661–9
   PubMed Web of Science ®Google Scholar
• Zbären P, Becker M, Läng H. Staging of laryngeal cancer: endoscopy, computed tomography and magnetic resonance versus histopathology. Eur Arch Oto-Rhino- Laryngol Suppl 1997; 50: 1172–80
   Google Scholar